Literature DB >> 1063066

Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.

J G Rosenstock, M H Donaldson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1063066

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  VM26: phase I and II studies.

Authors:  F R Macbeth
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 2.  The podophyllotoxin derivatives VP16-213 and VM26.

Authors:  B F Issell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.